After the vaccine of two companies in the war against the Coronavirus has been approved for emergency use, it may be difficult for the vaccine companies standing in front lines to be tested. There may be a problem with getting volunteers for their vaccines. It is known that on January 3 of this year, DCGI approved the Oxford Vaccine and indigenous Covaxin made at Serum Institute. Companies say recruitment has been adversely affected due to the news of the early availability of the vaccine.
Dr. V Krishna Mohan of Bharat Biotech said in a webinar, "There are several press releases without getting approval for emergency use, saying that their vaccine will be available soon." This is going to cause a lot of difficulty in recruitment, because most people are thinking about whether they should take part in clinical trials or not. After all, the vaccine is going to come soon. " Trials are taking place at the same time when the work of approving vaccines for emergency use is also going on in the country.
'Big challenge for India biotech'
He said that the challenge for Bharat Biotech was huge, as they were focusing on the older age group. He said that the oldest person to enroll for the covariate trial was 97. Mohan said, "Hospitals have also asked us whether it is morally right to continue clinical trials even when you have received emergency use. These questions should be answered. "Let us know that at least six human trials of corona vaccines are going on in the country. This is Zydus Cadila, which has recently started a third phase trial. Russia has Sputnik 5, whose second and third phase trials are being conducted by Dr. Reddy.
There is also an ongoing trial of these vaccines
Serum Institute of India also has the second vaccine Novavax, which is undergoing Phase II trials. Biological E and Genova are testing the first phase of their vaccine. Apart from this, work is also underway on another biotech vaccine of Bharat Biotech. Cadila Healthcare Chairperson Dr. Pankaj Patel also believes that recruitment time is going to be very challenging. He says the challenge will be to meet recruitment speed and volunteers. At the same time, there is also a concern that after the introduction of the vaccine, the weak people will get vaccinated soon.
External Affairs Minister Dr. S. Jaishankar, US Secretary of State Antony Blinken, Japanese Forei
The armies had shown their tactics at the second gate of the Chakravyuh. She has tried all her we
On the National Logistics Policy, Anurag Jain, Secretary, Department for Promotion of Industry an
There is relief from the cold in the plains of the country. Cold is being seen in the plains only
In an emotional blog written on the 100th birthday of his mother Heeraben, Prime Minister Narendr
There is good news for the students who could not take admission in class 10th-12th under the non
Know how long will Deepak Chahar be fit, big update on Washington Sundar's injury too
India's T20 specialist pacer Deepak Chahar will take some more time to fully recover from a hamst
You may have to pay a fee for the Twitter service. New boss Elon Musk is considering moving Twitt
With UK inflation rising to 9%, the living crisis facing students studying abroad is growing rapi
There will be no need to stand in long lines on the highway. Nor do you have to worry that you wi
